Healthcare provider profile · identity verified

Daniel Sizemore, MD

Family Practice · BOMOSEEN, VT · NPI 1952763815

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	647	183
Lisinopril	Lisinopril	377	114
Levothyroxine Sodium	Levothyroxine Sodium	361	100
Omeprazole	Omeprazole	345	94
Gabapentin	Gabapentin	300	65
Pantoprazole Sodium	Pantoprazole Sodium	293	75
Hydrochlorothiazide	Hydrochlorothiazide	291	82
Losartan Potassium	Losartan Potassium	289	85
Amlodipine Besylate	Amlodipine Besylate	259	73
Metoprolol Succinate	Metoprolol Succinate	248	75
Eliquis	Apixaban	186	37
Simvastatin	Simvastatin	181	47
Lorazepam	Lorazepam	180	43
Sertraline Hcl	Sertraline Hcl	179	46
Tamsulosin Hcl	Tamsulosin Hcl	172	47
Trazodone Hcl	Trazodone Hcl	167	40
Albuterol Sulfate Hfa	Albuterol Sulfate	162	48
Tramadol Hcl	Tramadol Hcl	150	29
Metformin Hcl	Metformin Hcl	125	40
Rosuvastatin Calcium	Rosuvastatin Calcium	120	37
Potassium Chloride	Potassium Chloride	119	32
Ozempic	Semaglutide	117	26
Jardiance	Empagliflozin	113	24
Metoprolol Tartrate	Metoprolol Tartrate	111	28
Allopurinol	Allopurinol	108	27
Duloxetine Hcl	Duloxetine Hcl	105	27
Fluticasone Propionate	Fluticasone Propionate	105	48
Oxycodone Hcl	Oxycodone Hcl	99	19
Diclofenac Sodium	Diclofenac Sodium	98	20
Metformin Hcl Er	Metformin Hcl	93	26
Prednisone	Prednisone	91	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	15
Spironolactone	Spironolactone	87	19
Clopidogrel	Clopidogrel Bisulfate	80	19
Furosemide	Furosemide	79	26
Alendronate Sodium	Alendronate Sodium	78	20
Escitalopram Oxalate	Escitalopram Oxalate	76	23
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	70	suppressed
Ezetimibe	Ezetimibe	70	18
Alprazolam	Alprazolam	66	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	23
Torsemide	Torsemide	63	19
Carvedilol	Carvedilol	61	14
Clonazepam	Clonazepam	61	suppressed
Pravastatin Sodium	Pravastatin Sodium	61	19
Citalopram Hbr	Citalopram Hydrobromide	59	15
Famotidine	Famotidine	58	24
Tizanidine Hcl	Tizanidine Hcl	57	16
Montelukast Sodium	Montelukast Sodium	56	13
Pregabalin	Pregabalin	56	14
Fentanyl	Fentanyl	55	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	52	suppressed
Mirtazapine	Mirtazapine	51	15
Symbicort	Budesonide/Formoterol Fumarate	50	suppressed
Bupropion Hcl Sr	Bupropion Hcl	49	11
Bupropion Xl	Bupropion Hcl	48	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	16
Farxiga	Dapagliflozin Propanediol	46	suppressed
Dexlansoprazole Dr	Dexlansoprazole	44	suppressed
Ventolin Hfa	Albuterol Sulfate	44	14
Zolpidem Tartrate	Zolpidem Tartrate	44	13
Incruse Ellipta	Umeclidinium Bromide	43	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	42	suppressed
Trulicity	Dulaglutide	42	11
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	12
Spiriva Respimat	Tiotropium Bromide	40	suppressed
Meloxicam	Meloxicam	39	12
Ibuprofen	Ibuprofen	38	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	38	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	12
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Finasteride	Finasteride	36	suppressed
Hydrocortisone	Hydrocortisone	36	suppressed
Arnuity Ellipta	Fluticasone Furoate	34	suppressed
Glimepiride	Glimepiride	33	suppressed
Spiriva Handihaler	Tiotropium Bromide	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Ramipril	Ramipril	30	suppressed
Fluconazole	Fluconazole	29	14
Lansoprazole	Lansoprazole	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	19
Ondansetron Odt	Ondansetron	27	suppressed
Temazepam	Temazepam	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Valsartan	Valsartan	26	suppressed
Baclofen	Baclofen	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Amoxicillin	Amoxicillin	24	18
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Naproxen	Naproxen	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	12
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	14
Fenofibrate	Fenofibrate	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Atenolol	Atenolol	18	suppressed
Lactulose	Lactulose	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Primidone	Primidone	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Risperidone	Risperidone	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Triazolam	Triazolam	14	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Prozac	Fluoxetine Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Verapamil Er	Verapamil Hcl	13	suppressed
Diazepam	Diazepam	12	suppressed
Methimazole	Methimazole	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nystatin	Nystatin	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Colchicine	Colchicine	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error